DNMT3B and neuroblastoma: We used 5-aza rather than PCA in the N2a cell lines, as 5-aza has been used regularly in N2a neuroblastoma cell lines [33, 34], and as we experienced an unintended (and likely compensatory) increase in DNMT3b gene expression level upon treatment with PCA (data not shown).